Overview

Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the response rate to treatment with pentostatin in steroid-refractory acute graft versus host disease.
Phase:
Phase 2
Details
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Treatments:
Pentostatin